scholarly article | Q13442814 |
review article | Q7318358 |
P356 | DOI | 10.1212/WNL.51.3.690 |
P698 | PubMed publication ID | 9748011 |
P2093 | author name string | Greenberg SM | |
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | cerebral amyloid angiopathy | Q191562 |
P304 | page(s) | 690-694 | |
P577 | publication date | 1998-09-01 | |
P1433 | published in | Neurology | Q1161692 |
P1476 | title | Cerebral amyloid angiopathy: prospects for clinical diagnosis and treatment | |
P478 | volume | 51 |
Q38404963 | 18F-AV-1451 PET Imaging in Three Patients with Probable Cerebral Amyloid Angiopathy. |
Q39766420 | 7 tesla MRI of microbleeds and white matter lesions as seen in vascular dementia |
Q30370833 | APOE ε variants increase risk of warfarin-related intracerebral hemorrhage. |
Q34341174 | Abeta is targeted to the vasculature in a mouse model of hereditary cerebral hemorrhage with amyloidosis. |
Q42621245 | Amyloid-peptide vaccinations reduce {beta}-amyloid plaques but exacerbate vascular deposition and inflammation in the retina of Alzheimer's transgenic mice |
Q30658000 | Analysis of cerebral amyloid angiopathy in a transgenic mouse model of Alzheimer disease using in vivo multiphoton microscopy |
Q48215367 | Apolipoprotein E markedly facilitates age-dependent cerebral amyloid angiopathy and spontaneous hemorrhage in amyloid precursor protein transgenic mice. |
Q37343428 | Association between Aortic Atheroma and Cerebral Small Vessel Disease in Patients with Ischemic Stroke. |
Q37251633 | Aβ-related angiitis: comparison with CAA without inflammation and primary CNS vasculitis |
Q38148437 | Brain regulation of thrombosis and hemostasis: from theory to practice |
Q35840033 | Cerebral amyloid angiopathy and thrombolysis-related intracerebral haemorrhage |
Q30801591 | Cerebral amyloid angiopathy associated with primary angiitis of the central nervous system: report of 2 cases and review of the literature |
Q74029881 | Cerebral amyloid angiopathy: a microvascular link between parenchymal and vascular dementia? |
Q53237896 | Cerebral beta amyloid angiopathy is a risk factor for cerebral ischemic infarction. A case control study in human brain biopsies. |
Q80903700 | Cerebral microbleeds in patients with hypertensive stroke. Topographical distribution in the supratentorial area |
Q34813136 | Cerebral microbleeds in the elderly: a pathological analysis |
Q37435248 | Cerebral microbleeds: a review of clinical, genetic, and neuroimaging associations |
Q26771852 | Cerebrovascular disease in ageing and Alzheimer's disease |
Q30544139 | Chronic rapamycin restores brain vascular integrity and function through NO synthase activation and improves memory in symptomatic mice modeling Alzheimer's disease |
Q30801544 | Clinical diagnosis of cerebral amyloid angiopathy: validation of the Boston criteria |
Q37596048 | Cortical atrophy in patients with cerebral amyloid angiopathy: a case-control study |
Q58284450 | Cortical petechial hemorrhage, subarachnoid hemorrhage and corticosteroid-responsive leukoencephalopathy in a patient with cerebral amyloid angiopathy |
Q38999340 | Current Perspective of Stem Cell Therapy in Neurodegenerative and Metabolic Diseases |
Q34065634 | Cystatin C--properties and use as diagnostic marker. |
Q44740563 | Cystatin forms a tetramer through structural rearrangement of domain-swapped dimers prior to amyloidogenesis |
Q52049515 | Dementia in hereditary cerebral hemorrhage with amyloidosis-Dutch type is associated with cerebral amyloid angiopathy but is independent of plaques and neurofibrillary tangles. |
Q35027659 | Diagnostic imaging for intracerebral hemorrhage |
Q36366572 | Diagnostic value of lobar microbleeds in individuals without intracerebral hemorrhage |
Q52665959 | Distinct structural changes in wild-type and amyloidogenic chicken cystatin caused by disruption of C95-C115 disulfide bond. |
Q48369492 | Encephalopathy with amyloid angiopathy and numerous amyloid plaques with low levels of CSF Aβ1-40/Aβ1-42. |
Q34386113 | Functional role of TGF beta in Alzheimer's disease microvascular injury: lessons from transgenic mice |
Q36993075 | Imaging Findings of Cerebral Amyloid Angiopathy, Aβ-Related Angiitis (ABRA), and Cerebral Amyloid Angiopathy-Related Inflammation: A Single-Institution 25-Year Experience |
Q22241491 | Immunotherapy as treatment for Alzheimer’s disease |
Q35142625 | Incidence of symptomatic hemorrhage in patients with lobar microbleeds |
Q28138617 | Inflammation and Alzheimer's disease |
Q52562977 | Innovative Magnetic Resonance Imaging Markers of Hereditary Cerebral Amyloid Angiopathy at 7 Tesla. |
Q82010316 | Intracerebral hemorrhage |
Q95480380 | Intracranial Hemorrhage in Patients with a Left Ventricular Assist Device |
Q48609636 | Longitudinal Positron Emission Tomography in Preventive Alzheimer's Disease Drug Trials, Critical Barriers from Imaging Science Perspective |
Q46678467 | Longitudinal neuropsychological findings in amyloid beta-related angiitis (AβRA): a case report |
Q42204077 | Management of Spontaneous Intracerebral Haemorrhage |
Q36173578 | Matrix metalloproteinase 9-mediated intracerebral hemorrhage induced by cerebral amyloid angiopathy. |
Q36448521 | Mechanism of cerebral beta-amyloid angiopathy: murine and cellular models |
Q36025087 | Mixed cerebrovascular disease and the future of stroke prevention |
Q35024976 | Molecular and functional dissection of TGF-beta1-induced cerebrovascular abnormalities in transgenic mice |
Q64241777 | Multiple Approaches to Diffusion Magnetic Resonance Imaging in Hereditary Cerebral Amyloid Angiopathy Mutation Carriers |
Q37772789 | Neuropathology after active Abeta42 immunotherapy: implications for Alzheimer's disease pathogenesis. |
Q47801818 | Neuropsychological Features of Microbleeds and Cortical Microinfarct Detected by High Resolution Magnetic Resonance Imaging |
Q36104043 | New horizons for primary intracerebral hemorrhage treatment: experience from preclinical studies |
Q35949979 | No neuropathological evidence for a direct topographical relation between microbleeds and cerebral amyloid angiopathy |
Q33654643 | Occludin deficiency with BACE1 elevation in cerebral amyloid angiopathy. |
Q48952517 | Outcome of cerebral amyloid angiopathic brain haemorrhage |
Q48805579 | Primary central nervous system vasculitis presenting with intracranial hemorrhage |
Q46407220 | Primary central nervous system vasculitis: comparison of patients with and without cerebral amyloid angiopathy |
Q38824828 | Recurrent hemorrhage risk and mortality in hereditary and sporadic cerebral amyloid angiopathy |
Q47891553 | Resumption of Anticoagulation After Intracranial Hemorrhage |
Q37800132 | Review: sporadic cerebral amyloid angiopathy |
Q48327668 | Smooth muscle cells and the pathogenesis of cerebral microvascular disease (“angiomyopathies”) |
Q48974670 | Spontaneous hemorrhagic stroke in a mouse model of cerebral amyloid angiopathy. |
Q36260752 | Sporadic cerebral amyloid angiopathy: pathology, clinical implications, and possible pathomechanisms. |
Q42746027 | Superficial siderosis in cerebral amyloid angiopathy |
Q38533776 | The Inflammatory Form of Cerebral Amyloid Angiopathy or "Cerebral Amyloid Angiopathy-Related Inflammation" (CAARI). |
Q36448518 | The cerebral beta-amyloid angiopathies: hereditary and sporadic |
Q43838647 | The distribution of cerebral microbleeds determines their association with arterial stiffness in non-cardioembolic acute stroke patients. |
Q38969718 | The impact of cerebrovascular aging on vascular cognitive impairment and dementia. |
Q45908398 | The relationship between rebleeding after spontaneous SAH and APOE polymorphisms in a Chinese population. |
Q28307028 | The role of cystatin C in cerebral amyloid angiopathy and stroke: cell biology and animal models |
Q44033124 | Toxicity of substrate-bound amyloid peptides on vascular smooth muscle cells is enhanced by homocysteine |
Q33950435 | Vascular abnormalities: the insidious pathogenesis of Alzheimer's disease |
Q34449070 | Vasculitis. A collection of pearls and myths |
Q38038399 | What's hAPPening at synapses? The role of amyloid β-protein precursor and β-amyloid in neurological disorders |
Q79783584 | [Cerebral amyloid angiopathy] |
Q52939626 | [Sporadic cerebral amyloid angiopathy with ischemic leukoencephalopathy and microbleeds. Cause for a rapidly progressive dementia syndrome]. |
Q46452092 | β-Amyloid in CSF: Biomarker for preclinical cerebral amyloid angiopathy |
Search more.